Jorfi, Samireh <br/><br/>
Inhibition of microvesiculation sensitizes prostate cancer cells to chemotherapy and reduces docetaxel dose required to limit tumor growth in vivo.  [electronic resource] 

 -  Scientific reports  Aug 2015 
 - 13006 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>2045-2322 
<br/><br/><label>Standard No.: </label>10.1038/srep13006  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Animals<br/>Antineoplastic Agents--administration & dosage<br/>Apoptosis--drug effects<br/>Calpain--antagonists & inhibitors<br/>Cell Line, Tumor<br/>Cell Proliferation--drug effects<br/>Cell-Derived Microparticles--drug effects<br/>Dipeptides--administration & dosage<br/>Docetaxel<br/>Dose-Response Relationship, Drug<br/>Drug Synergism<br/>Humans<br/>Male<br/>Mice<br/>Mice, Nude<br/>Prostatic Neoplasms--drug therapy<br/>Taxoids--administration & dosage<br/>Treatment Outcome